Synaptogenix Inc (SNPX)

[runncoach]

Nobody knows for sure. I absolutely do believe it hits 20 but I'm a proponent of these additional trials adding value that keeps this from being an all or nothing proposition. I said that last go around as well but they never got the MS trial or FragileX up and running for various reasons ranging from money to availability of the drug to additional studies and just about had to close up shop.

The first go around we ran up to nearly a 250 million market cap (not fully diluted fyi). Last go around I think it was around 125 million (someone correct me if I'm wrong).

Will it be different this time? We do have a lot more going for us. We do have a longer trial that we know doesn't have a baseline balance this go around for one. Lots of reasons to think the trial would be more likely to be successful but whether that impacts a price run up to 40 dollars to be the equivalent of the first trial, we simply do not know. I figure 20 is highly likely. We've already seen around 14 twice already and the 1-year warrants will expire at least 6 months before trial results to take any increased selling off the table. JMHO